• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

JAK/STAT和VEGF/PAK1信号通路作为银屑病局部治疗的新兴靶点:一项初步研究。

JAK/STAT and VEGF/PAK1 signaling as emerging targets for topical treatment of psoriasis: a pilot study.

作者信息

Du Yang, Jiang Shukun, Cheng Longlong, Liu Jihui

机构信息

The 7th People's Hospital of Shenyang Shenyang, Liaoning Province, P. R. China.

Department of Forensic Clinical Medicine, School of Forensic Medicine, China Medical University Shenyang, Liaoning Province, P. R. China.

出版信息

Int J Clin Exp Pathol. 2020 Dec 1;13(12):3111-3119. eCollection 2020.

PMID:33425111
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7791387/
Abstract

Psoriasis is reportedly modulated by the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) or vascular endothelial growth factor/p21-activated kinase 1 (VEGF/PAK1) pathways. However, no research has evaluated the expression of JAK/STAT and VEGF/PAK1 signaling pathway molecules in human psoriasis skin tissue concurrently. We investigated the expression of autocrine STAT1, STAT3, VEGF, suppressor of cytokine signaling-1 (SOCS1), SOCS3, and PAK1 in psoriatic tissues. Skin biopsies were retrospectively collected from 55 patients with psoriasis from the tissue biobank. Skin biopsies from 40 healthy volunteers undergoing plastic surgery were used as controls. Immunohistochemical staining revealed that STAT1, STAT3, SOCS1, SOCS3, VEGF, and PAK1 were present at significantly higher levels in the psoriasis samples compared to the control group. Similarly, the mRNA expression of these signaling molecules was also significantly upregulated in psoriatic skin. Additionally, some of the molecules in these two signaling pathways exhibited significant positive correlations. In summary, we present pilot evidence that JAK/STAT and VEGF/PAK1 signaling molecules are expressed in psoriasis, which may provide topical treatment targets for this disease.

摘要

据报道,银屑病受Janus激酶(JAK)/信号转导子和转录激活子(STAT)或血管内皮生长因子/p21激活激酶1(VEGF/PAK1)信号通路调控。然而,尚无研究同时评估JAK/STAT和VEGF/PAK1信号通路分子在人银屑病皮肤组织中的表达情况。我们研究了自分泌信号分子STAT1、STAT3、VEGF、细胞因子信号抑制因子1(SOCS1)、SOCS3和PAK1在银屑病组织中的表达。回顾性收集了组织生物样本库中55例银屑病患者的皮肤活检样本。选取40例接受整形手术的健康志愿者的皮肤活检样本作为对照。免疫组化染色显示,与对照组相比,银屑病样本中STAT1、STAT3、SOCS1、SOCS3、VEGF和PAK1的表达水平显著更高。同样,这些信号分子的mRNA表达在银屑病皮肤中也显著上调。此外,这两条信号通路中的一些分子呈现出显著的正相关。总之,我们提供的初步证据表明,JAK/STAT和VEGF/PAK1信号分子在银屑病中表达,这可能为该病提供局部治疗靶点。

相似文献

1
JAK/STAT and VEGF/PAK1 signaling as emerging targets for topical treatment of psoriasis: a pilot study.JAK/STAT和VEGF/PAK1信号通路作为银屑病局部治疗的新兴靶点:一项初步研究。
Int J Clin Exp Pathol. 2020 Dec 1;13(12):3111-3119. eCollection 2020.
2
Calpastatin counteracts pathological angiogenesis by inhibiting suppressor of cytokine signaling 3 degradation in vascular endothelial cells.钙蛋白酶抑制蛋白通过抑制血管内皮细胞中细胞因子信号转导抑制因子 3 的降解来拮抗病理性血管生成。
Circ Res. 2015 Mar 27;116(7):1170-81. doi: 10.1161/CIRCRESAHA.116.305363. Epub 2015 Feb 3.
3
Interleukin-17 upregulates vascular endothelial growth factor by activating the JAK/STAT pathway in nucleus pulposus cells.白细胞介素-17通过激活髓核细胞中的JAK/STAT通路来上调血管内皮生长因子。
Joint Bone Spine. 2017 May;84(3):327-334. doi: 10.1016/j.jbspin.2016.05.014. Epub 2016 Jul 15.
4
Selective Immunomodulation of Inflammatory Pathways in Keratinocytes by the Janus Kinase (JAK) Inhibitor Tofacitinib: Implications for the Employment of JAK-Targeting Drugs in Psoriasis.角质形成细胞中 Janus 激酶(JAK)抑制剂托法替尼对炎症途径的选择性免疫调节:在银屑病中应用 JAK 靶向药物的意义。
J Immunol Res. 2018 Nov 19;2018:7897263. doi: 10.1155/2018/7897263. eCollection 2018.
5
Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis.细胞因子信号转导抑制因子在动脉粥样硬化过程中调节JAK/STAT介导的细胞反应。
Arterioscler Thromb Vasc Biol. 2009 Apr;29(4):525-31. doi: 10.1161/ATVBAHA.108.173781. Epub 2009 Jan 22.
6
Effect of liraglutide on the Janus kinase/signal transducer and transcription activator (JAK/STAT) pathway in diabetic kidney disease in db/db mice and in cultured endothelial cells.利拉鲁肽对 db/db 小鼠糖尿病肾病和培养的内皮细胞中 Janus 激酶/信号转导和转录激活因子(JAK/STAT)通路的影响。
J Diabetes. 2019 Aug;11(8):656-664. doi: 10.1111/1753-0407.12891. Epub 2019 Feb 28.
7
AICAR, an AMPK activator, protects against cisplatin-induced acute kidney injury through the JAK/STAT/SOCS pathway.AICAR,一种 AMPK 激活剂,通过 JAK/STAT/SOCS 通路保护顺铂诱导的急性肾损伤。
Biochem Biophys Res Commun. 2019 Feb 12;509(3):680-686. doi: 10.1016/j.bbrc.2018.12.159. Epub 2019 Jan 4.
8
The hepatitis C virus (HCV) protein, p7, suppresses inflammatory responses to tumor necrosis factor (TNF)-α signal transducer and activator of transcription (STAT)3 and extracellular signal-regulated kinase (ERK)-mediated induction of suppressor of cytokine signaling (SOCS)3.丙型肝炎病毒(HCV)蛋白 p7 抑制肿瘤坏死因子(TNF)-α 信号转导和转录激活因子(STAT)3 以及细胞外信号调节激酶(ERK)介导的细胞因子信号转导抑制物(SOCS)3 诱导的炎症反应。
FASEB J. 2019 Aug;33(8):8732-8744. doi: 10.1096/fj.201800629RR. Epub 2019 Jun 4.
9
Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1.在过表达细胞因子信号转导抑制因子1的人角质形成细胞中,干扰素-γ依赖性炎症反应受损。
J Immunol. 2002 Jul 1;169(1):434-42. doi: 10.4049/jimmunol.169.1.434.
10
6-Hydroxy-3-O-methyl-kaempferol 6-O-glucopyranoside potentiates the anti-proliferative effect of interferon α/β by promoting activation of the JAK/STAT signaling by inhibiting SOCS3 in hepatocellular carcinoma cells.6-羟基-3-O-甲基山奈酚6-O-吡喃葡萄糖苷通过抑制肝细胞癌细胞中的SOCS3来促进JAK/STAT信号通路的激活,从而增强干扰素α/β的抗增殖作用。
Toxicol Appl Pharmacol. 2017 Dec 1;336:31-39. doi: 10.1016/j.taap.2017.10.004. Epub 2017 Oct 12.

引用本文的文献

1
Essential thrombocythemia as an initial presentation of polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes syndrome with complete response to the bortezomib, cyclophosphamide, dexamethasone regimen: a case report.原发性血小板增多症作为多神经病、器官肿大、内分泌病、M蛋白、皮肤改变综合征的初始表现,对硼替佐米、环磷酰胺、地塞米松方案完全缓解:一例报告
J Med Case Rep. 2025 Jul 1;19(1):301. doi: 10.1186/s13256-025-05338-4.
2
Yinxie I Formula attenuates imiquimod-induced psoriasis-like skin inflammation via IL-23/IL-17 axis.银屑 I 方通过 IL-23/IL-17 轴减轻咪喹莫特诱导的银屑病样皮肤炎症。
Arch Dermatol Res. 2024 Aug 19;316(8):540. doi: 10.1007/s00403-024-03288-3.
3
Inflammatory Skin Diseases: Focus on the Role of Suppressors of Cytokine Signaling (SOCS) Proteins.炎症性皮肤病:聚焦细胞因子信号转导抑制蛋白(SOCS)的作用。
Cells. 2024 Mar 13;13(6):505. doi: 10.3390/cells13060505.
4
Role of Cyclins and Cytoskeletal Proteins in Endometriosis: Insights into Pathophysiology.细胞周期蛋白和细胞骨架蛋白在子宫内膜异位症中的作用:对病理生理学的见解
Cancers (Basel). 2024 Feb 19;16(4):836. doi: 10.3390/cancers16040836.
5
Baricitinib treatment for refractory skin changes in POEMS syndrome: a case report.巴瑞替尼治疗POEMS综合征难治性皮肤改变:一例报告
Front Pharmacol. 2023 Sep 12;14:1191158. doi: 10.3389/fphar.2023.1191158. eCollection 2023.
6
Platelet activation: a promoter for psoriasis and its comorbidity, cardiovascular disease.血小板活化:银屑病及其合并症、心血管疾病的促进因素。
Front Immunol. 2023 Aug 15;14:1238647. doi: 10.3389/fimmu.2023.1238647. eCollection 2023.
7
miRNA expression profiles of the perilesional skin of atopic dermatitis and psoriasis patients are highly similar.特应性皮炎和银屑病患者皮损周围皮肤的 miRNA 表达谱高度相似。
Sci Rep. 2022 Dec 31;12(1):22645. doi: 10.1038/s41598-022-27235-2.
8
A Dietary Oxysterol, 7-Ketocholesterol, Exacerbates Imiquimod-Induced Psoriasis-like Dermatitis in Steatohepatitic Mice.一种膳食氧化固醇 7-酮胆固醇可加剧 steatohepatitic 小鼠的咪喹莫特诱导的银屑病样皮炎。
Int J Mol Sci. 2022 Dec 13;23(24):15855. doi: 10.3390/ijms232415855.
9
[Recent research on tofacitinib in the treatment of pediatric rheumatic diseases].[托法替布治疗儿童风湿性疾病的最新研究]
Zhongguo Dang Dai Er Ke Za Zhi. 2022 Apr 15;24(4):447-453. doi: 10.7499/j.issn.1008-8830.2201081.

本文引用的文献

1
The influence of ustekinumab on expression of STAT1, STAT3, STAT4, SOCS2, and IL17 in patients with psoriasis and in a control.乌司奴单抗对银屑病患者及对照者中 STAT1、STAT3、STAT4、SOCS2 和 IL17 表达的影响。
Dermatol Ther. 2019 Sep;32(5):e13029. doi: 10.1111/dth.13029. Epub 2019 Jul 22.
2
Immunohistochemical study of janus kinase 1/signal transducer and activator of transcription 3 in psoriasis vulgaris.寻常型银屑病中Janus激酶1/信号转导及转录激活因子3的免疫组织化学研究
Clin Cosmet Investig Dermatol. 2019 Jul 2;12:497-508. doi: 10.2147/CCID.S202835. eCollection 2019.
3
AIN-93 Diet as an Alternative Model to Lieber-DeCarli Diet for Alcoholic Cardiomyopathy.AIN-93 饮食作为酒精性心肌病的 Lieber-DeCarli 饮食替代模型。
Alcohol Clin Exp Res. 2019 Jul;43(7):1452-1461. doi: 10.1111/acer.14069. Epub 2019 May 23.
4
STAT1 activation represses IL-22 gene expression and psoriasis pathogenesis.STAT1 激活抑制 IL-22 基因表达和银屑病发病机制。
Biochem Biophys Res Commun. 2018 Jun 22;501(2):563-569. doi: 10.1016/j.bbrc.2018.05.042.
5
The role of regulatory T cells and anti-inflammatory cytokines in psoriasis.调节性T细胞和抗炎细胞因子在银屑病中的作用。
Acta Dermatovenerol Alp Pannonica Adriat. 2018 Mar;27(1):17-23.
6
Granule Attenuates Diabetic Retinopathy in Type 2 Diabetes Rats.颗粒剂减轻2型糖尿病大鼠的糖尿病视网膜病变。
Front Physiol. 2017 Dec 19;8:1065. doi: 10.3389/fphys.2017.01065. eCollection 2017.
7
Vascular endothelial growth factor (VEGF) gene polymorphisms (rs699947, rs833061, and rs2010963) and psoriatic risk in South Indian Tamils.血管内皮生长因子(VEGF)基因多态性(rs699947、rs833061和rs2010963)与南印度泰米尔人的银屑病风险
Hum Immunol. 2017 Oct;78(10):657-663. doi: 10.1016/j.humimm.2017.08.004. Epub 2017 Aug 10.
8
Autocrine VEGF and IL-8 Promote Migration via Src/Vav2/Rac1/PAK1 Signaling in Human Umbilical Vein Endothelial Cells.自分泌血管内皮生长因子和白细胞介素-8通过Src/Vav2/Rac1/PAK1信号通路促进人脐静脉内皮细胞迁移。
Cell Physiol Biochem. 2017;41(4):1346-1359. doi: 10.1159/000465389. Epub 2017 Mar 9.
9
Inhibition of group 1 p21-activated kinases suppresses pancreatic stellate cell activation and increases survival of mice with pancreatic cancer.抑制 p21 激活激酶组 1 可抑制胰腺星状细胞活化,提高胰腺癌小鼠的存活率。
Int J Cancer. 2017 May 1;140(9):2101-2111. doi: 10.1002/ijc.30615. Epub 2017 Feb 7.
10
Effects of Traditional Chinese Medicine, Dilong Injection, on Random Skin Flap Survival in Rats.中药地龙注射液对大鼠随意皮瓣存活的影响。
J Invest Surg. 2018 Feb;31(1):38-43. doi: 10.1080/08941939.2016.1273981. Epub 2017 Jan 20.